Key Takeaways
- In 2022, the South Korean plastic surgery market was valued at approximately 5.5 billion USD, marking a 10% year-over-year growth driven by medical tourism.
- The plastic surgery industry in South Korea generated over 4.8 trillion KRW in revenue in 2021, with projections to reach 6 trillion KRW by 2025.
- Medical tourism for plastic surgery contributed 1.2 billion USD to South Korea's economy in 2019, representing 25% of total medical tourism revenue.
- In 2022, South Korea performed 1,135 aesthetic procedures per 1,000 population, leading the world.
- Double eyelid surgery (blepharoplasty) accounted for 19.2% of all procedures in 2022, totaling over 250,000 cases.
- Rhinoplasty procedures numbered 180,000 in South Korea in 2021, up 15% from 2020.
- Women aged 19-29 comprised 42% of all plastic surgery patients in 2022.
- Male patients increased to 25% of total in 2023, up from 15% in 2018.
- 65% of South Korean women in their 20s have undergone or considered plastic surgery per 2022 survey.
- There were 2,450 certified plastic surgery clinics in South Korea as of 2023.
- Over 5,200 board-certified plastic surgeons practiced in 2022, ratio 1 per 10,000 people.
- Gangnam district hosted 600 plastic surgery clinics, 25% of national total in 2023.
- AI-assisted planning used in 35% of clinics by 2023.
- 3D simulation tech adopted by 70% of clinics, reducing revisions by 18% in 2022.
- Stem cell therapies in fat grafting trials showed 25% better retention in 2023 studies.
South Korea's massive plastic surgery industry thrives on both domestic demand and international medical tourism.
Consumer Demographics
- Women aged 19-29 comprised 42% of all plastic surgery patients in 2022.
- Male patients increased to 25% of total in 2023, up from 15% in 2018.
- 65% of South Korean women in their 20s have undergone or considered plastic surgery per 2022 survey.
- Foreign patients made up 18% of plastic surgery cases in 2022, totaling 120,000 visitors.
- Chinese nationals accounted for 52% of international plastic surgery patients in 2019.
- Average age of first-time surgery patients dropped to 24 years in 2022 from 28 in 2015.
- 78% of procedures were sought for employment or social reasons in 2021 Gallup poll.
- High school students undergoing surgery rose 12% in 2022, despite regulations.
- 35% of patients were repeat customers in 2023, averaging 2.5 procedures lifetime.
- Urban residents from Seoul and Gyeonggi accounted for 72% of patients in 2022.
- Income level: 55% of patients earned over 50 million KRW annually in 2022 survey.
- Social media influence cited by 62% of young patients in 2023 study.
- Japanese patients dropped to 15% post-COVID but rebounded to 20% in 2023.
- Southeast Asian patients (Thai, Vietnamese) rose to 22% of foreigners in 2022.
- 48% of female office workers in Seoul had procedures by age 30 per 2022 poll.
- LGBTQ+ individuals represented 8% of patients in anonymous 2023 survey.
- Patient satisfaction rate averaged 92% for eyelid surgeries in 2022 clinics data.
- 72% of patients under 40 years old in 2022 national data.
- Single women: 38% of patients, seeking confidence boost 2022.
- 82% of international patients female, average stay 10 days 2023.
- Post-college grads (22-25): peak age group at 35% share.
- 45% cite K-pop idols as influence in 2023 youth survey.
- Rural patients: 18%, traveling to Seoul for procedures.
- Average procedures per patient: 1.8 lifetime in 2022 cohort.
- Europeans: 5% of medical tourists, preferring subtlety.
- Salarywomen (office): 55% of female patients 2022.
- 92% satisfaction overall, but 18% seek touch-ups.
Consumer Demographics Interpretation
Market Statistics
- In 2022, the South Korean plastic surgery market was valued at approximately 5.5 billion USD, marking a 10% year-over-year growth driven by medical tourism.
- The plastic surgery industry in South Korea generated over 4.8 trillion KRW in revenue in 2021, with projections to reach 6 trillion KRW by 2025.
- Medical tourism for plastic surgery contributed 1.2 billion USD to South Korea's economy in 2019, representing 25% of total medical tourism revenue.
- From 2016 to 2022, the CAGR of the Korean cosmetic surgery market stood at 9.8%, fueled by rising disposable incomes.
- In 2023, the non-surgical aesthetics segment in South Korea accounted for 45% of the total plastic surgery market value, estimated at 2.8 billion USD.
- South Korea's plastic surgery exports, including training and technology, reached 500 million USD in 2022.
- The industry employed over 120,000 people directly and indirectly in 2022, with 30% growth in jobs since 2018.
- Average revenue per plastic surgery clinic in Seoul's Gangnam district was 1.2 billion KRW in 2021.
- Plastic surgery spending per capita in South Korea reached 110 USD in 2022, highest globally.
- The market share of laser-based aesthetic treatments grew to 22% of total revenue in 2023.
- In 2022, South Korea led globally with 13.5 surgical procedures per 1,000 people.
- The industry saw a 15% revenue spike in Q1 2023 due to pent-up demand.
- Export of cosmetic devices from Korea hit 1.1 billion USD in 2022.
- Per capita spending on aesthetics: 250,000 KRW average in 2022.
- E-commerce for post-op care products generated 300 billion KRW in 2023.
Market Statistics Interpretation
Procedure Statistics
- In 2022, South Korea performed 1,135 aesthetic procedures per 1,000 population, leading the world.
- Double eyelid surgery (blepharoplasty) accounted for 19.2% of all procedures in 2022, totaling over 250,000 cases.
- Rhinoplasty procedures numbered 180,000 in South Korea in 2021, up 15% from 2020.
- Liposuction surgeries reached 110,000 cases in 2022, representing 12% of surgical procedures.
- Breast augmentation procedures totaled 85,000 in 2022, with silicone implants preferred in 70% of cases.
- Facelifts numbered 45,000 in South Korea in 2022, a 20% increase post-pandemic.
- Botox injections were administered 1.2 million times in 2022, dominating non-surgical procedures.
- Filler injections reached 950,000 procedures in 2021, with hyaluronic acid used in 88%.
- Thread lifts performed 65,000 times in 2022, growing 25% annually.
- Jaw reduction surgeries (V-line) totaled 55,000 cases in 2022, popular among young adults.
- Skin resurfacing laser treatments numbered 400,000 in 2023, up 18% from prior year.
- Fat grafting procedures hit 75,000 in 2022, often combined with other surgeries.
- 68% of procedures in 2022 were on women, but male procedures rose to 32%.
- Under-30 age group underwent 52% of all plastic surgeries in 2022.
- Revision surgeries accounted for 15% of total procedures in 2021.
- Combined eyelid and nose jobs made up 28% of multi-procedure cases in 2022.
- Non-surgical rhinoplasty with fillers grew 30% to 40,000 cases in 2023.
- Calf reduction surgeries numbered 12,000 in 2022, niche but popular.
- Hair transplantation procedures reached 25,000 for aesthetic purposes in 2022.
- 55,000 rhinoplasties were revision cases in 2022, 22% of total noses.
- Hyaluronic acid fillers dominated with 720,000 injections in 2022.
- Breast implant removals rose 28% to 15,000 amid natural trend 2023.
- Facial contouring (cheekbone, jaw) totaled 90,000 surgeries 2022.
- Laser lipolysis procedures: 80,000 in 2022, non-invasive shift.
- 1.8 million total aesthetic procedures (surg + non-surg) in 2022.
- Eyelid ptosis correction: 35,000 cases, functional-cosmetic hybrid.
- Men’s gynecomastia surgeries: 12,000 in 2022, up 40%.
- 28% of procedures combined surgery + injectables in 2023.
- Americans visiting for surgery: 8,000 in 2022, 7% of foreigners.
Procedure Statistics Interpretation
Professional Data
- There were 2,450 certified plastic surgery clinics in South Korea as of 2023.
- Over 5,200 board-certified plastic surgeons practiced in 2022, ratio 1 per 10,000 people.
- Gangnam district hosted 600 plastic surgery clinics, 25% of national total in 2023.
- Average surgeon experience: 12 years, with 75% having international training.
- Clinic accreditation rate: 85% of top clinics ISO-certified in 2022.
- Annual surgeries per surgeon averaged 450 in high-volume clinics in 2022.
- 40% of surgeons specialize in facial contouring procedures as of 2023.
- Nurse-to-surgeon ratio in top clinics: 3:1, supporting 24/7 care in 2022.
- Investment in clinic tech averaged 2 billion KRW per new facility in 2023.
- 92% of clinics offer English services for international patients in 2022.
- Malpractice insurance coverage: 100% mandatory, claims rose 5% to 1,200 in 2022.
- Training programs graduated 250 new specialists annually from 2020-2023.
- Top 10 clinics performed 15% of national procedures in 2022.
- Surgeon salary averaged 250 million KRW yearly in Seoul 2023.
- 3,100 total aesthetic clinics including dermatology in 2023.
- Female surgeons: 28% of total, rising trend 2023.
- Procedures per clinic: 1,200 annually average 2022.
- International society members: 1,200 Korean surgeons 2023.
- Consultation fees average 100,000 KRW in Gangnam 2023.
- 65% clinics offer package deals for tourists 2022.
- Complication reporting: 2.5% rate officially 2022.
- Residency slots: 80 per year for plastics 2023.
- Hotel partnerships: 400 clinics with 4-star stays.
- Revenue per surgeon: 180 million KRW mid-tier 2022.
Professional Data Interpretation
Trends & Innovations
- AI-assisted planning used in 35% of clinics by 2023.
- 3D simulation tech adopted by 70% of clinics, reducing revisions by 18% in 2022.
- Stem cell therapies in fat grafting trials showed 25% better retention in 2023 studies.
- Ultrasound-guided injections improved accuracy to 98% in Botox procedures 2023.
- Minimally invasive PDO threads evolved to barbed variants, used in 80% lifts 2022.
- Robot-assisted rhinoplasty piloted in 5 clinics, precision up 30% in 2023 trials.
- Exosome-based skin rejuvenation gained 40% market share in non-surgical 2023.
- Personalized genomics for procedure planning in 15% elite clinics 2023.
- VR recovery simulations reduced patient anxiety by 22% per 2022 study.
- Bio-printing for custom implants tested, FDA approval pending 2024.
- HIFU (high-intensity focused ultrasound) treatments surged 35% to 150,000 in 2023.
- Nano-fat grafting innovations boosted volume retention to 75% in 2022 trials.
- AR mirrors for pre-op visualization in 50% Gangnam clinics 2023.
- Blockchain for patient records adopted by 20% clinics for privacy 2023.
- Long-acting fillers lasted 24 months, capturing 28% market in 2023.
- Regenerative medicine integration in 45% procedures 2023.
- Wireless RF devices for home-use post-care booming.
- CRISPR skin editing in R&D phase, trials 2025.
- Droplet Botox micro-dosing: 50% less product 2023.
- Hybrid ORs with robotics in 12 premium clinics.
- Metaverse consultations: 10,000 sessions 2023 pilots.
- Collagen stimulators overtook fillers in cheeks 2023.
- Wearables track swelling, used by 25% patients post-op.
- Natural-look trend: 60% prefer subtle changes 2023.
- Scaffolding threads with growth factors: new 2023 std.
Trends & Innovations Interpretation
Sources & References
- Reference 1STATISTAstatista.comVisit source
- Reference 2KOREATIMESkoreatimes.co.krVisit source
- Reference 3KOREABIOMEDkoreabiomed.comVisit source
- Reference 4GRANDVIEWRESEARCHgrandviewresearch.comVisit source
- Reference 5MORDORINTELLIGENCEmordorintelligence.comVisit source
- Reference 6KHIDIkhidi.or.krVisit source
- Reference 7MEDICALKOREAmedicalkorea.or.krVisit source
- Reference 8KOREAHERALDkoreaherald.comVisit source
- Reference 9ISAPSisaps.orgVisit source
- Reference 10MARKETSANDMARKETSmarketsandmarkets.comVisit source
- Reference 11MFDSmfds.go.krVisit source
- Reference 12KOSTATkostat.go.krVisit source
- Reference 13GALLUPgallup.co.krVisit source
- Reference 14NCBIncbi.nlm.nih.govVisit source
- Reference 15JKAMSjkams.orgVisit source
- Reference 16MOHWmohw.go.krVisit source
- Reference 17KAHPkahp.or.krVisit source
- Reference 18JKAPSjkaps.orgVisit source
- Reference 19KSAPSksaps.or.krVisit source
- Reference 20SARAMINsaramin.co.krVisit source
- Reference 21JPRASjpras.comVisit source
- Reference 22AESTHETICMEDICINEJOURNALaestheticmedicinejournal.comVisit source
- Reference 23NATUREnature.comVisit source
- Reference 24PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 25DERMATOLOGYTIMESdermatologytimes.comVisit source





